Visionary Wealth Advisors Makes New $1.24 Million Investment in CVS Health Corporation $CVS

Visionary Wealth Advisors bought a new position in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 11,986 shares of the pharmacy operator’s stock, valued at approximately $1,240,000.

A number of other institutional investors also recently modified their holdings of CVS. Caitong International Asset Management Co. Ltd boosted its holdings in CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares during the period. Swiss RE Ltd. bought a new stake in CVS Health during the 4th quarter valued at $26,000. Kilter Group LLC purchased a new stake in shares of CVS Health during the second quarter worth $27,000. Sankala Group LLC bought a new position in shares of CVS Health in the fourth quarter worth $28,000. Finally, Global Trust Asset Management LLC grew its position in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 300 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Argus boosted their price objective on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday, August 19th. DA Davidson lifted their target price on CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. upped their price target on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research report on Thursday, August 6th. Finally, Sanford C. Bernstein boosted their price objective on shares of CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Stock Performance

Shares of CVS opened at $94.06 on Tuesday. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The company has a market cap of $120.31 billion, a PE ratio of 24.88, a price-to-earnings-growth ratio of 0.85 and a beta of 0.61. The stock has a 50-day moving average price of $101.88 and a 200-day moving average price of $89.08.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same period in the prior year, the business earned $1.81 earnings per share. CVS Health’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.